Skip to Content

Fluarix Approval History

FDA Approved: Yes (First approved August 31, 2005)
Brand name: Fluarix
Generic name: influenza virus vaccine, inactivated
Company: GlaxoSmithKline
Treatment for: Influenza Prophylaxis

Fluarix (influenza virus vaccine, inactivated) is an influenza virus vaccine indicated for the prevention of influenza.

Development History and FDA Approval Process for Fluarix

Jan 11, 2018Approval GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
Dec 17, 2012Approval FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
Oct 19, 2009Approval FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Aug 31, 2005Approval Fluarix GlaxoSmithKline - Treatment for Influenza Vaccination
May 25, 2005GlaxoSmithKline Submits Biologics License Application for FDA Approval of Fluarix

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.